Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU570
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,188
Award facts
- Contract value 100% obligated
- $43,187.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) on December 9, 2025, for the supply of GARDASIL 9 syringes (0.5 mL). The contract ceiling value is $43,187.80, with an ultimate completion date of December 10, 2025. The place of performance is located in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside contract with no small business designation restrictions. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026.
As a pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical medical commodities to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. GARDASIL 9 is an immunological product used for cancer prevention and is part of standard military preventive healthcare protocols. The company's extensive portfolio of federal contract awards demonstrates capability in fulfilling diverse pharmaceutical procurement requirements through open competition. This delivery order represents a routine execution of AmerisourceBergen's broader pharmaceutical supply agreement with the DLA, supporting the agency's ongoing medical logistics operations.
Quick answers
Who was awarded contract SPE2DR26FU570?
SPE2DR26FU570 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FU570 worth?
The government has obligated $43,188 on SPE2DR26FU570.
Is contract SPE2DR26FU570 an order under another contract?
Yes. SPE2DR26FU570 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU570 competed?
The extent of competition for SPE2DR26FU570 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award